STOCK TITAN
  1. Home
  2. Sec-filings
  3. KNSA
  4. [Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity

[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock KNSA logo
Kiniksa Pharmaceuticals International, plc

NASDAQ:KNSA

KNSA Rankings

#2931 Ranked by Market Cap
N/A Ranked by Dividends

KNSA Latest News

Jun 5, 2025
Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis
May 29, 2025
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
Apr 30, 2025
Kiniksa Pharmaceuticals Announces GRAMMY® Award-Winning Country Star, Carly Pearce, Joins the Life DisRPted™ Campaign, Adding to Voices Advocating for Awareness of Recurrent Pericarditis
Apr 29, 2025
Kiniksa Pharmaceuticals Reports First Quarter 2025 Financial Results and Recent Portfolio Execution
Apr 24, 2025
Kiniksa Pharmaceuticals to Report First Quarter 2025 Financial Results on April 29, 2025

KNSA Latest SEC Filings

Jul 14, 2025
[144] Kiniksa Pharmaceuticals International, plc SEC Filing
Jul 9, 2025
[SCHEDULE 13G/A] Kiniksa Pharmaceuticals International, plc SEC Filing
Jul 3, 2025
[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity
Jun 18, 2025
[Form 4] Kiniksa Pharmaceuticals International, plc Insider Trading Activity

KNSA Stock Data

2.11B
40.70M
4.01%
89.92%
4.13%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United Kingdom
LONDON